TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
+0.77 (+1.99%)39.30USD2.2M成交股數–市值–本益比(近四季)–股價營收比-0.8%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 4.1B-1% | 4.0B+2% | 1.5B-65% | 4.5B+3% | 4.2B+0% | 3.9B+2% | 4.2B+10% | 4.3B+12% | 4.2B | 3.8B | 3.9B | 3.9B |
| 營業成本 | 2.0B | 2.0B | – | 2.2B | 2.1B | 2.0B | 2.1B | 2.2B | 2.1B | 2.0B | 2.0B | 2.1B |
| 毛利 | 2.2B+2% | 2.0B+5% | – | 2.3B+7% | 2.1B+4% | 1.9B+6% | 2.1B+15% | 2.1B+20% | 2.0B | 1.8B | 1.9B | 1.8B |
| 毛利率 | 52.0% | 49.5% | – | 51.4% | 50.3% | 48.2% | 50.2% | 49.6% | 48.6% | 46.4% | 48.1% | 46.3% |
| 研發費用 | 970M | 222M | – | 256M | 244M | 247M | 247M | 240M | 269M | 242M | 253M | 240M |
| 銷售管理費用 | 317M | 304M | – | 317M | 305M | 297M | 302M | 298M | 283M | 278M | 268M | 307M |
| 營業利益 | −231M-151% | 652M+26% | – | 882M-1829% | 455M-9200% | 519M-338% | −29.0M-108% | −51.0M-92% | −5.0M | −218M | 344M | −654M |
| 營業利益率 | -5.6% | 16.4% | – | 19.7% | 10.9% | 13.3% | -0.7% | -1.2% | -0.1% | -5.7% | 8.9% | -16.9% |
| 稅後淨利 | −576M-304% | 369M+72% | – | 433M-199% | 282M-133% | 214M-254% | −217M-414% | −437M-50% | −846M | −139M | 69.0M | −872M |
| 淨利率 | -13.9% | 9.3% | – | 9.7% | 6.8% | 5.5% | -5.1% | -10.1% | -20.3% | -3.6% | 1.8% | -22.5% |
| 稀釋 EPS | -0.49-304% | 0.31+72% | – | 0.37-195% | 0.24-132% | 0.18-250% | -0.19-417% | -0.39-50% | -0.75 | -0.12 | 0.06 | -0.78 |
| 稀釋股數 | 1.17B | 1.18B | – | 1.16B | 1.16B | 1.16B | 1.13B | 1.13B | 1.13B | 1.12B | 1.14B | 1.12B |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.7B | 3.7B | 3.6B | 2.2B | 2.2B | 1.7B | 3.3B | 3.3B | 2.3B | 3.0B | 2.2B | 2.7B |
| 應收帳款 | 3.5B | 3.4B | 3.7B | 3.8B | 3.6B | 3.4B | 3.1B | 3.5B | 3.8B | 3.5B | 3.4B | 3.5B |
| 存貨 | 3.2B | 3.2B | 3.2B | 3.3B | 3.5B | 3.2B | 3.0B | 4.0B | 3.9B | 3.9B | 4.1B | 4.1B |
| 總資產 | 39.9B | 40.0B | 40.7B | 39.9B | 40.1B | 38.4B | 39.3B | 41.8B | 41.3B | 42.8B | 42.1B | 43.1B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 32.1B | 31.8B | 32.8B | 32.6B | 33.3B | 32.1B | 33.6B | 35.4B | 34.8B | 35.2B | 34.7B | 35.5B |
| 股東權益 | 7.8B | 8.2B | 7.9B | 7.3B | 6.8B | 6.3B | 5.4B | 6.1B | 6.4B | 7.3B | 6.9B | 7.1B |
| 負債比 | 80.5% | 79.4% | 80.6% | 81.8% | 83.0% | 83.7% | 85.5% | 84.7% | 84.1% | 82.4% | 82.5% | 82.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 411M+81% | −40.0M-62% | – | 369M-47% | 227M+120% | −105M-15% | 575M+11400% | 693M+114% | 103M | −124M | 5.0M | 324M |
| 資本支出 | 104M | 168M | – | 136M | 96.0M | 127M | 129M | 148M | 97.0M | 124M | 149M | 119M |
| 自由現金流 | 307M+134% | −208M-10% | – | 233M-57% | 131M+2083% | −232M-6% | 446M-410% | 545M+166% | 6.0M | −248M | −144M | 205M |
| 折舊攤銷 | 241M | 239M | – | 249M | 251M | 244M | 269M | 259M | 259M | 272M | 283M | 300M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | 7.4% | -5.2% | – | 5.2% | 3.1% | -6.0% | 10.5% | 12.6% | 0.1% | -6.5% | -3.7% | 5.3% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 17.3B
| 美國 | 9.2B | 53.2% | +14.3% |
|---|---|---|---|
| 歐洲 | 5.0B | 29.2% | -1.2% |
| International Markets | 2.2B | 12.5% | -12.2% |
| Other Activities | 870M | 5.0% | -7.8% |
地區2025 年度 · 14.2B
| 美國 | 9.2B | 64.6% | +14.3% |
|---|---|---|---|
| 歐洲 | 5.0B | 35.4% | -1.2% |
產品／服務2025 年度 · 17.3B
| 產品 | 14.6B | 84.6% | +4.0% |
|---|---|---|---|
| Distribution Service | 1.6B | 9.0% | -1.6% |
| License | 678M | 3.9% | +291.9% |
| Product And Service Other | 423M | 2.5% | -43.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 17.3B | +4.3% | 1.4B | 8.2% | 1.21 | 1.1B |
| FY2024 | 16.5B | +4.4% | −1.6B | -9.9% | -1.45 | 749M |
| FY2023 | 15.8B | +6.2% | −559M | -3.5% | -0.50 | 842M |
| FY2022 | 14.9B | -6.0% | −2.4B | -16.4% | -2.20 | 1.0B |
| FY2021 | 15.9B | -4.7% | 417M | 2.6% | 0.38 | 236M |
| FY2020 | 16.7B | -1.4% | −4.0B | -24.0% | -3.64 | 638M |
| FY2019 | 16.9B | -7.6% | −999M | -5.9% | -0.91 | 223M |
| FY2018 | 18.3B | – | −2.2B | -11.8% | -2.35 | 1.8B |